ACLX

Arcellx, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$114.77

Market Cap

$6.71B

Beta

0.23

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-79.35%

EPS Growth (YoY)-100.00%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-3.17%

Debt / Equity0.24

Interest Coverage-10.5x

No credit card required

Already have an account? Sign in to view the full analysis for ACLX.